Archer-Daniels-Midland Company appointed Jeffrey Rowe as Executive Vice President and Chief Operating Officer, effective August 17, 2026. Rowe joins from Syngenta Group, where he served as CEO since January 2024. His compensation package includes an annual base salary of $1,200,000, an annual target equity award of $12,500,000, and a 2026 equity award valued at $11,100,000. Additionally, he will receive make-whole awards consisting of a $2,200,000 cash bonus payable in January 2027 and $16,690,000 in RSUs to replace forfeited incentives from his previous employer. Rowe will oversee commercial businesses, global manufacturing, and R&D, reporting to CEO Juan Luciano. The company is a global agricultural supply chain manager and processor that provides human and animal nutrition and bio-based solutions.

Archer-Daniels-Midland Company stockholders approved an amendment to the 2020 Incentive Compensation Plan, increasing the number of shares available for issuance by 9,000,000. This expansion of the equity pool represents a potential source of future dilution for existing shareholders.

Archer-Daniels-Midland Company (ADM) has released its first quarter financial results via an official press release. This announcement is a critical event for investors to evaluate the company's recent operational performance and overall financial health.

Archer-Daniels-Midland Company expanded its Board of Directors from 12 to 13 members following the election of Michael C. McMurray as an independent director. Mr. McMurray will serve on the Audit and Sustainability and Technology Committees, providing additional oversight in key governance and strategic areas.

Archer-Daniels-Midland Company (ADM) has released its fourth quarter and annual financial results. This announcement is a key event for investors as it provides the latest data regarding the company's operational performance and annual profitability.

Archer-Daniels-Midland has settled an SEC investigation into intersegment sales by agreeing to a $40 million civil penalty and has also been cleared of further investigation by the DOJ. This settlement resolves significant regulatory uncertainty regarding the company's Nutrition and Agriculture segments. Management expects the penalty to have no material adverse effect on the company's overall financial position.